ARCHIVES

Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February

This article is from The Cancer Letter archive.

Vol. 03 No. 42 | October 21, 1977

Download PDF Visit The Full Archive

Related Articles

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

December 2, 2011

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

NIH Acting Director Kirschstein Preparing For Budget Hearings.

January 14, 2000

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

NCAB Subcommittee Approves Compromise On Changes In Organ Site Program

April 9, 1982

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007